Back
Supernus Pharmaceuticals Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
48
SUPN
Supernus Pharmaceuticals
Last Price:
36.57
Seasonality Move:
5.14%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Supernus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.41 | Buy |
| 20-day SMA: | 34.44 | Buy |
| 50-day SMA: | 33.16 | Buy |
| 200-day SMA: | 30.69 | Buy |
| 8-day EMA: | 35.66 | Buy |
| 20-day EMA: | 34.59 | Buy |
| 50-day EMA: | 33.37 | Buy |
| 200-day EMA: | 31.24 | Buy |
Supernus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.96 | Buy |
| Relative Strength Index (14 RSI): | 65.66 | Buy |
| Chaikin Money Flow: | 309767 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.58 - 35.38) | Buy |
| Bollinger Bands (100): | (28.66 - 34.48) | Buy |
Supernus Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals Stock
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 36.61 while SUPN 8-day simple moving average is 35.41, which is a Buy signal.
- The stock price of SUPN is 36.61 while Supernus Pharmaceuticals 20-day SMA is 34.44, which makes it a Buy.
- Supernus Pharmaceuticals 50-day simple moving average is 33.16 while SUPN share price is 36.61, making it a Buy technically.
- SUPN stock price is 36.61 and Supernus Pharmaceuticals 200-day simple moving average is 30.69, creating a Buy signal.
SUPN Technical Analysis vs Fundamental Analysis
Sell
48
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a Sell
The current Supernus Pharmaceuticals [SUPN] share price is $36.61. The Score for SUPN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Supernus Pharmaceuticals Stock Info
Market Cap:
2.02B
Price in USD:
36.61
Share Volume:
494.54K
Supernus Pharmaceuticals 52-Week Range
52-Week High:
39.37
52-Week Low:
25.53
Sell
48
Supernus Pharmaceuticals (SUPN)
is a Sell
Supernus Pharmaceuticals Share Price Forecast
-
What is the Supernus Pharmaceuticals stock price today?
The Supernus Pharmaceuticals stock price is 36.61 USD today. -
Will SUPN stock go up or go down?
Supernus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Supernus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals is overvalued.
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 36.61 while SUPN 8-day exponential moving average is 35.66, which is a Buy signal.
- The stock price of SUPN is 36.61 while Supernus Pharmaceuticals 20-day EMA is 34.59, which makes it a Buy.
- Supernus Pharmaceuticals 50-day exponential moving average is 33.37 while SUPN share price is 36.61, making it a Buy technically.
- SUPN stock price is 36.61 and Supernus Pharmaceuticals 200-day simple moving average is 31.24, creating a Buy signal.
Fundamental Analysis of Supernus Pharmaceuticals
Is Supernus Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and a decrease next year of $0.96 per share.
Technical Analysis of Supernus Pharmaceuticals
Should I short Supernus Pharmaceuticals stock?
- SUPN Moving Average Covergence Divergence (MACD) indicator is 0.96, suggesting Supernus Pharmaceuticals is a Buy
- Supernus Pharmaceuticals Relative Strength Index (RSI) is 65.66, which suggest Supernus Pharmaceuticals is overbought
- The Bollinger Bands (25) for Supernus Pharmaceuticals is (32.58 - 35.38), which suggest Supernus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Supernus Pharmaceuticals is (28.66 - 34.48), which suggest Supernus Pharmaceuticals is a Buy
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.